We used a mouse model to develop the disease model of early‐stage NAFLD via low‐density lipoprotein receptor knockout (Ldlr−/−) mice and a high‐fat diet regimen. This evidence concerns the gene LDLR and metabolic dysfunction-associated steatotic liver disease.